Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)
Turn Bankers’ Pay Into Shareholder Protection: Naylor
54:36 - Bartlett Naylor of Public Citizen Financial discusses his proposal on management pay at Citigroup and measures by shareholders to take on big banks. He speaks on “Market Makers.” (Source: Bloomberg)
  • Tight Race for Goodluck Jonathan in Nigeria’s Election
  • Miliband: Cameron Is Rattled, Running From Record
  • Senator Reid Won’t Run Again